|
US6572862B1
(en)
|
1989-11-08 |
2003-06-03 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize Norwalk and related viruses
|
|
AU1893592A
(en)
|
1991-03-25 |
1992-10-21 |
Board Of Trustees Of The Leland Stanford Junior University |
Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas
|
|
EP0635056A1
(en)
|
1992-04-08 |
1995-01-25 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Wild-type measles virus glycoproteins: vaccine and detection method therefor
|
|
JPH08500250A
(ja)
|
1992-09-07 |
1996-01-16 |
ベイラー・カレッジ・オブ・メディシン |
ノーウォークおよび関連ウイルスを検出し、かつ特徴付けるための方法並びに試薬
|
|
US5776468A
(en)
|
1993-03-23 |
1998-07-07 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
|
|
US5788970A
(en)
|
1994-03-29 |
1998-08-04 |
The University Of Maryland College Park |
Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
|
|
ATE328068T1
(de)
|
1994-05-16 |
2006-06-15 |
Merck & Co Inc |
Papillomavirus vakzine
|
|
US5645051A
(en)
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
|
US5861241A
(en)
|
1995-08-16 |
1999-01-19 |
University Of Massachusetts |
Monoclonal antibodies for detecting Norwalk virus
|
|
GB9525083D0
(en)
|
1995-12-07 |
1996-02-07 |
Danbiosyst Uk |
Vaccine compositions
|
|
US5834015A
(en)
*
|
1996-09-11 |
1998-11-10 |
Albany Medical College |
Protein-lipid vesicles and autogenous vaccine comprising the same
|
|
US5953727A
(en)
|
1996-10-10 |
1999-09-14 |
Incyte Pharmaceuticals, Inc. |
Project-based full-length biomolecular sequence database
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
PT973546E
(pt)
|
1997-04-08 |
2004-06-30 |
Merck & Co Inc |
Formulacoes estabilizadas de virus de papiloma humano
|
|
AU750702B2
(en)
|
1997-05-01 |
2002-07-25 |
Chiron Corporation |
Use of virus-like particles as adjuvants
|
|
US20040265377A1
(en)
|
1997-10-27 |
2004-12-30 |
Harry Seager |
Solid dispersing vaccine composition for oral delivery
|
|
HUP0103091A3
(en)
|
1998-08-14 |
2002-03-28 |
Merck & Co Inc |
Process for purifying human papillomavirus virus-like particles
|
|
WO2000035479A1
(en)
|
1998-12-17 |
2000-06-22 |
Merck & Co., Inc. |
Synthetic virus-like particles with heterologous epitopes
|
|
AU764138B2
(en)
*
|
1999-02-05 |
2003-08-14 |
Merck Sharp & Dohme Corp. |
Human papilloma virus vaccine formulations
|
|
KR100771402B1
(ko)
|
1999-06-22 |
2007-10-30 |
국립감염증연구소장이 대표하는 일본국 |
Ｓｒｓｖ 검출 킷트
|
|
JP2002020399A
(ja)
|
2000-07-10 |
2002-01-23 |
Osaka Prefecture |
ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
US20040121465A1
(en)
|
2002-02-14 |
2004-06-24 |
Novavax, Inc. |
Optimization of gene sequences of virus-like particles for expression in insect cells
|
|
GB0206360D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
GB0206359D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
WO2003087327A2
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
|
JP2006507800A
(ja)
|
2002-06-07 |
2006-03-09 |
ラージ・スケール・バイオロジー・コーポレイション |
可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
|
|
BR0311995A
(pt)
|
2002-06-20 |
2005-04-05 |
Cytos Biotechnology Ag |
Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
|
|
CA2514667C
(en)
|
2003-01-30 |
2013-01-08 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
US20040213745A1
(en)
|
2003-02-20 |
2004-10-28 |
Vincent Sullivan |
Powder formulations of rSEB for improved vaccination
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
WO2005032457A2
(en)
|
2003-07-21 |
2005-04-14 |
Boyce Thompson Institute For Plant Research, Inc. |
Vectors and methods for immunization against norwalk virus using transgenic plants
|
|
JP2007537137A
(ja)
|
2003-09-24 |
2007-12-20 |
モンタナ ステート ユニバーシティ |
ノロウィルスモノクローナル抗体及びペプチド
|
|
WO2005037223A2
(en)
|
2003-10-15 |
2005-04-28 |
Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
|
FR2863890B1
(fr)
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
US20050260225A1
(en)
|
2004-05-18 |
2005-11-24 |
Goldberg Joanna B |
Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
|
|
CU23496A1
(es)
|
2004-09-03 |
2010-02-23 |
Ct Ingenieria Genetica Biotech |
Composición vacunal contra el virus de la hepatitis c
|
|
SG156666A1
(en)
|
2004-10-20 |
2009-11-26 |
Acambis Inc |
Vaccines against japanese encephalitis virus and west nile virus
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
US20060177468A1
(en)
|
2005-01-05 |
2006-08-10 |
Philadelphia Health and Education Corporation (d/b/a Drexel University College of Medicine |
Delivery vehicles, bioactive substances and viral vaccines
|
|
EP1846439A2
(en)
|
2005-01-31 |
2007-10-24 |
The Johns Hopkins University |
Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|
|
ZA200707413B
(en)
|
2005-03-18 |
2009-01-28 |
Cytos Biotechnology Ag |
Cat allergen fusion proteins and uses thereof
|
|
BRPI0611336A2
(pt)
|
2005-06-01 |
2010-08-31 |
Dow Global Technologies Inc |
método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina
|
|
EP1736538A1
(en)
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
|
JP2007145775A
(ja)
|
2005-11-29 |
2007-06-14 |
Falco Life Science:Kk |
ノロウイルスｇｉの高感度検出方法
|
|
US20080029915A1
(en)
*
|
2006-08-02 |
2008-02-07 |
Courtoy Nv |
Rotary tablet press
|
|
EP2066354B1
(en)
|
2006-09-29 |
2013-04-17 |
Ligocyte Pharmaceuticals, Inc. |
Norovirus vaccine formulations
|
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
|
WO2008113011A2
(en)
*
|
2007-03-14 |
2008-09-18 |
Ligocyte Pharmaceuticals, Inc. |
Virus like particle purification
|
|
AU2008299589B2
(en)
|
2007-09-12 |
2014-06-26 |
Australian Centre For Plant Functional Genomics Pty Ltd |
Plant seed active transcriptional control sequences
|
|
US20100266636A1
(en)
|
2007-09-18 |
2010-10-21 |
Ligocyte Pharmaceuticals, Inc. |
Method of conferring a protective immune response to norovirus
|
|
CN104740624B
(zh)
|
2007-09-18 |
2018-04-24 |
武田疫苗股份有限公司 |
赋予针对诺如病毒的保护性免疫应答的疫苗
|
|
NO2324113T3
(enExample)
|
2008-08-08 |
2018-07-28 |
|
|
|
WO2010084298A1
(en)
*
|
2009-01-22 |
2010-07-29 |
Pharmathene Uk Limited |
Stable vaccine compositions and methods of use
|
|
EA201171032A1
(ru)
*
|
2009-02-10 |
2012-02-28 |
Новартис Аг |
Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами
|
|
US20110070260A1
(en)
|
2009-09-09 |
2011-03-24 |
Baric Ralph S |
Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use
|
|
CA2787666A1
(en)
|
2010-01-21 |
2011-07-28 |
Ligocyte Pharmaceuticals, Inc. |
Targeted heterologous antigen presentation on calicivirus virus-like particles
|
|
CA2798739A1
(en)
*
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
EP4112074A1
(en)
|
2011-07-11 |
2023-01-04 |
Takeda Vaccines, Inc. |
Parenteral norovirus vaccine formulations
|
|
JOP20130186B1
(ar)
|
2012-06-22 |
2021-08-17 |
Takeda Vaccines Montana Inc |
تنقية الجزيئات الشبيهة بالفيروسات
|
|
EP3827838B1
(en)
|
2015-12-16 |
2023-06-07 |
The Walter and Eliza Hall Institute of Medical Research |
Inhibition of cytokine-induced sh2 protein in nk cells
|
|
CN110520530A
(zh)
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
KR20210005240A
(ko)
|
2018-05-03 |
2021-01-13 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
면역 관문 차단과 함께 키메라 항원 수용체를 발현하도록 가공된 천연 킬러 세포
|
|
US20210308249A1
(en)
|
2018-08-20 |
2021-10-07 |
Takeda Vaccines, Inc. |
Vlp formulations
|
|
AR117462A1
(es)
|
2018-12-20 |
2021-08-04 |
Takeda Vaccines Inc |
Vacuna contra norovirus, formulaciones y métodos
|
|
PE20211959A1
(es)
|
2019-02-15 |
2021-09-30 |
Editas Medicine Inc |
Celulas asesinas naturales (nk) modificadas para inmunoterapia
|